首页> 外文期刊>Journal of cataract and refractive surgery >Laser-assisted subepithelial keratectomy retreatment after laser in situ keratomileusis.
【24h】

Laser-assisted subepithelial keratectomy retreatment after laser in situ keratomileusis.

机译:激光原位角膜磨镶术后激光辅助上皮下角膜切除术的再治疗。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: To evaluate the efficacy and safety of laser-assisted subepithelial keratectomy (LASEK) retreatment after laser in situ keratomileusis (LASIK). SETTING: Mater Private Hospital, Dublin, Ireland. METHODS: In this retrospective study, 22 eyes of 20 patients had LASEK retreatment for residual refractive errors after LASIK. All patients who had the procedure between January 2004 and May 2007 were included in the study. The main outcome measures at the final follow-up visit were efficacy, predictability, safety, and stability. RESULTS: The mean spherical equivalent (SE) was -4.50 diopters (D)+/-2.88 (SD) (range -10.00 to +3.87 D) before LASIK and -1.23+/-0.95 D (range -2.50 to +2.00 D) after LASIK. The mean time between the initial LASIK procedure and LASEK enhancement was 56.2+/-24.3 months (range 6 to 84 months). The mean follow-up after retreatment was 6.68+/-6.47 months (range 3 to 24 months). At the final follow-up visit, 19 eyes (86.4%) had an uncorrected visual acuity of 20/30 or better and 17 eyes (77.3%) were within +/-1.00 D of the target refraction. No patient lost more than 1 line of best corrected visual acuity or developed corneal haze greater than grade 1. CONCLUSION: Results indicate that LASEK retreatment after LASIK is a safe and effective alternative when LASIK retreatment is deemed unsafe because there is not sufficient residual corneal stromal bed or when retreatment is required many years after LASIK and relifting the original flap is expected to be problematic.
机译:目的:评估激光原位角膜磨镶术(LASIK)后激光辅助上皮下角膜切除术(LASEK)复治的疗效和安全性。地点:爱尔兰都柏林马特私人医院。方法:在这项回顾性研究中,对20例患者的22眼进行了LASEK复治,以治疗LASIK后残留的屈光不正。在2004年1月至2007年5月期间进行手术的所有患者均纳入研究。最后一次随访时的主要结局指标是疗效,可预测性,安全性和稳定性。结果:LASIK手术前的平均球面等效(SE)为-4.50屈光度(D)+/- 2.88(SD)(范围-10.00至+3.87 D)和-1.23 +/- 0.95 D(范围-2.50至+2.00 D )。初始LASIK手术与LASEK增强之间的平均时间为56.2 +/- 24.3个月(6到84个月)。再治疗后的平均随访时间为6.68 +/- 6.47个月(3至24个月)。在最后的随访中,有19眼(86.4%)的未矫正视力为20/30或更好,有17眼(77.3%)的屈光度在目标屈光度的+/- 1.00 D以内。结论:结果表明,当由于没有足够的残留角膜基质而将LASIK复治视为不安全时,结果表明当认为LASIK复治不安全时,LASIK复治是安全有效的替代方法床或在LASIK手术后多年需要重新治疗并重新抬起原始皮瓣可能会出现问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号